Federal Requirements is 18.75% of the scored PTCE (the PTCB exam). Answer 10 exam style questions on FDA recalls and DSCSA drug tracing and see exactly which concepts would cost you points on test day.
Start the 10 questions →A lot of tablets is recalled because some bottles contain a different, potent drug, and taking it could cause serious harm or death. Which FDA recall class applies?
These questions cover FDA recalls: Class I, FDA recalls: Class II, FDA recalls: pharmacy response, federal drug law: DSCSA and FDA recalls: classification. Each one shows the correct answer and why every other option is wrong, so a miss tells you exactly what to review before the PTCE.
Prefer to read first? Every question from the practice set above, with the correct answer and why each wrong option is wrong.
Answer: D. Class I is the most serious recall: there is a reasonable probability that using the product will cause serious adverse health consequences or death. A wrong drug in the bottle with risk of serious harm fits Class I.
Why not A: Class II covers products that may cause temporary or medically reversible effects, or where serious harm is remote.
Why not B: Class III covers products that are not likely to cause adverse health consequences, such as minor labeling defects.
Why not C: A market withdrawal involves a minor violation or no violation, not a risk of death.
Exam tactic: Serious harm or death likely = Class I.
Answer: B. Class II recalls involve products whose use may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse consequences is remote.
Why not A: Class I requires a reasonable probability of serious harm or death, which is not the case here.
Why not C: Class III is for products not likely to cause any adverse health consequences. Here temporary effects are possible.
Why not D: There is no Class IV. FDA recalls are Class I, II or III.
Exam tactic: Temporary or reversible harm = Class II.
Answer: C. When a recall notice arrives, the pharmacy checks its inventory for the affected lot, pulls the product from the shelves, quarantines it in a labeled area, and follows the notice for return and any patient notification.
Why not A: Only the affected lot is recalled. Destroying stock is not the usual instruction; product is quarantined and returned.
Why not B: The pharmacy acts on the recall notice. It does not wait for a call from the FDA.
Why not D: Recalled product must be removed from use, not dispensed.
Exam tactic: Recall: match the lot number, pull, quarantine, follow the notice.
Answer: C. The Drug Supply Chain Security Act (DSCSA, 2013) builds an electronic system to identify and trace prescription drugs through the supply chain. Trading partners must exchange and keep transaction information to keep counterfeit and illegitimate drugs out.
Why not A: The CMEA limits pseudoephedrine sales. It does not cover product tracing.
Why not B: The PPPA requires child-resistant packaging, not supply chain tracing.
Why not D: HIPAA protects health information privacy. It does not govern product tracing.
Exam tactic: Track and trace through the supply chain = DSCSA.
Answer: B. Most drug recalls are started voluntarily by the manufacturer, but the FDA evaluates the health hazard and assigns the recall classification.
Why not A: The DEA regulates controlled substances. It does not classify drug recalls.
Why not C: The manufacturer starts the recall, but the FDA assigns the class.
Why not D: Wholesalers help distribute recall notices but do not classify recalls.
Exam tactic: Manufacturer recalls, FDA classifies.
Answer: B. The DSCSA requires the product identifier data to be in a 2-dimensional data matrix barcode on the package, alongside human-readable text. Scanning it lets trading partners trace the package and verify that it is legitimate.
Why not A: Price is not part of the DSCSA data carried by the 2D barcode.
Why not C: The NDC is still part of the product identifier and still appears on the label.
Why not D: The barcode identifies the package; it does not list authorized buyers.
Exam tactic: Square 2D barcode on the package = DSCSA product identifier.
Answer: C. A product with reason to believe it may be counterfeit, diverted, stolen or otherwise unfit is a suspect product. The pharmacy must quarantine it (keep it physically separate and clearly identified so it cannot be distributed) and investigate it with its trading partners.
Why not A: Shelving it mixes a suspect product with saleable stock.
Why not B: A suspect product must not be dispensed while it is under investigation.
Why not D: Discarding it destroys the evidence needed for the investigation and skips the required steps.
Exam tactic: Suspect product: separate it, label it, investigate. Never shelve or dispense it.
Answer: D. Once a dispenser determines that a product is illegitimate, it must notify FDA (using Form FDA 3911) and all appropriate immediate trading partners within 24 hours after making that determination.
Why not A: 30 days is far too late; the federal deadline is 24 hours.
Why not B: 7 days is not the DSCSA deadline; notification is due within 24 hours.
Why not C: The biennial inventory is a controlled substance requirement and has nothing to do with DSCSA notifications.
Exam tactic: Illegitimate product confirmed = notify FDA and trading partners within 24 hours.
Answer: A. Federal law defines a suspect product as one where there is reason to believe it is potentially counterfeit, diverted, stolen or otherwise unfit for distribution. An illegitimate product is one where credible evidence shows that it is.
Why not B: Recalls and expiration dates are separate topics; they do not define these two terms.
Why not C: Both terms apply to any prescription drug product covered by the DSCSA, not only controlled substances.
Why not D: The law defines them separately, and each one triggers different steps.
Exam tactic: Suspect = reason to believe. Illegitimate = credible evidence.
Answer: B. Under the DSCSA, a dispenser's trading partners may be only authorized trading partners, which for a wholesale distributor means one with the required license or registration. Buying from an unlicensed seller is not allowed and is a common way counterfeit product enters the supply chain.
Why not A: Documentation does not make an unauthorized trading partner legal.
Why not C: Inspecting the product does not fix the fact that the seller is not authorized.
Why not D: There is no small-quantity exception for buying from an unauthorized seller.
Exam tactic: No license or registration = not an authorized trading partner = do not buy.
The free 20 question diagnostic covers all 4 areas of the PTCE outline and shows the 3 fixes worth the most points.
Take the free diagnosticSee all 31 PTCB practice topics →